Abstract
In a year in which regulators and drug companies gained familiarity with risk management strategies, the number of new drug approvals was similar to that in 2008.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
